Reporting of adverse events following immunizations in Ghana - Using disproportionality analysis reporting ratios

被引:4
作者
Ankrah, Daniel N. A. [1 ,2 ]
Darko, Delese M. [3 ]
Sabblah, George [3 ]
Mantel-Teeuwisse, Aukje [2 ]
Leufkens, Hubert M. G. [2 ,4 ]
机构
[1] Korle Bu Teaching Hosp, Dept Pharm, Korle Bu, Accra, Ghana
[2] UIPS, Div Pharmacoepidemiol & Clin Pharmacol, Utrecht, Netherlands
[3] Food & Drugs Author, Cantonments Accra, Ghana
[4] Med Evaluat Board, Utrecht, Netherlands
关键词
active surveillance; Ghana; immunization; proportional reporting ratio; safety; SIGNAL-DETECTION; HUMAN-PAPILLOMAVIRUS; CONJUGATE VACCINE; SURVEILLANCE; DATABASE; SYSTEMS; SAFETY;
D O I
10.1080/21645515.2017.1384105
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Background: Timely reporting of safety information post vaccination is pivotal for the success of any vaccination program. Reports of adverse events following immunization (AEFI) of 6 different vaccinations from Ghana were analysed for signals.Methods: De-identified data from active surveillance for AEFIs after 2009 AH1N1 influenza, yellow fever, meningitis, measles-rubella, pneumococcal-rotavirus and human papilloma virus vaccinations were used. All vaccinations occurred between January 2010 and December 2013. The ten most occurring events for each vaccination were captured and arranged using Medical Dictionary for Regulatory Authorities (MedDRA) Preferred Term (PT) and System Organ Classification (SOC) codes. Adverse event incidence rates were calculated for each vaccine type, and signals were generated using proportional reporting ratios (PRR).Results: A total number of 5,141 reports were analysed ranging from 33 (human papilloma virus) to 1958 (measles-rubella). Between 22% and 55% of all AEFIs per vaccine type were collected on the day of vaccination. For each vaccine type, at least 87% of all reported AEFIs occurred in the first 7days post-vaccination. Multiple reports were received per vaccine type. For the MR vaccine, urticarial recorded the highest attack rate of 6.6 (95% CI 6.2, 7.1) per 100,000 vaccines. The AEFI with the highest PRR for both human papilloma and measles-rubella vaccines was abdominal pain, recording a PRR of 8.15 (95% CI 3.46, 19.23) and 43.75 (95% CI 17.81, 107.45) respectively.Conclusion: These results underscore the competency of public health systems in sub-Saharan African countries (like Ghana) to identify most frequently occurring and important vaccine related safety issues.
引用
收藏
页码:172 / 178
页数:7
相关论文
共 34 条
  • [1] Incidence of Adverse Events Among Healthcare Workers Following H1N1 Mass Immunization in Ghana
    Ankrah, Daniel N. A.
    Mantel-Teeuwisse, Aukje K.
    De Bruin, Marie L.
    Amoo, Philip K.
    Ofei-Palm, Charles N.
    Agyepong, Irene
    Leufkens, Hubert G. M.
    [J]. DRUG SAFETY, 2013, 36 (04) : 259 - 266
  • [2] [Anonymous], 2016, PUBL HLTH BREAKTHR
  • [3] [Anonymous], 2014, FDA GHANA NEWSLETTER, V2, P5
  • [4] A Bayesian neural network method for adverse drug reaction signal generation
    Bate, A
    Lindquist, M
    Edwards, IR
    Olsson, S
    Orre, R
    Lansner, A
    De Freitas, RM
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1998, 54 (04) : 315 - 321
  • [5] Guidelines for collection, analysis and presentation of vaccine safety data in surveillance systems
    Bonhoeffer, Jan
    Bentsi-Enchill, Adwoa
    Chen, Robert T.
    Fisher, Margaret C.
    Gold, Michael S.
    Hartman, Katharina
    Heininger, Ulrich
    Hoet, Bernard
    Jefferson, Thomas
    Khuri-Bulos, Najwa
    Kohl, Katrin
    Marcy, S. Michael
    Nalin, David
    Pless, Robert
    Sanabria-Rojas, Hernan
    Sleeman, Karen
    Se, Robert W.
    [J]. VACCINE, 2009, 27 (16) : 2289 - 2297
  • [6] Centers for Disease Control and Prevention. Centers for Disease Control and Prevention, 2009 H1N1 FLU SIT UP
  • [7] Monitoring adverse events following immunization with a new conjugate vaccine against group A meningococcus in Niger, September 2010
    Chaibou, Maman S.
    Bako, Harouna
    Salisou, Laouali
    Yameogo, Tene M.
    Sambo, Mariama
    Kim, Sung Hye
    Djingarey, Mamoudou H.
    Zuber, Patrick L. F.
    Perea, William A.
    Pezzoli, Lorenzo
    [J]. VACCINE, 2012, 30 (35) : 5229 - 5234
  • [8] Ellenberg SS, 1997, PUBLIC HEALTH REP, V112, P10
  • [9] Prescription-event monitoring - Developments in signal detection
    Ferreira, Germano
    [J]. DRUG SAFETY, 2007, 30 (07) : 639 - 641
  • [10] Galindo BM, 2012, MEDICC REV, V14, P38, DOI 10.37757/MR2012V14.N1.8